0000874015-18-000033.txt : 20180131 0000874015-18-000033.hdr.sgml : 20180131 20180131161525 ACCESSION NUMBER: 0000874015-18-000033 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180129 FILED AS OF DATE: 20180131 DATE AS OF CHANGE: 20180131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROOKE STANLEY T CENTRAL INDEX KEY: 0000897667 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 18562913 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4/A 1 edgar.xml PRIMARY DOCUMENT X0306 4/A 2018-01-29 2018-01-29 0000874015 IONIS PHARMACEUTICALS INC IONS 0000897667 CROOKE STANLEY T C/O IONIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 1 1 0 0 Chairman and CEO Common Stock 2018-01-29 2018-01-29 4 M 0 10000 14.69 A 61733 D Common Stock 2018-01-29 2018-01-29 4 S 0 10000 54.12 D 51733 D Common Stock 2018-01-29 2018-01-29 4 M 0 1000 10.82 A 5128 I By wife Common Stock 2018-01-29 2018-01-29 4 S 0 1000 54.12 D 4128 I By wife Common Stock 725391 I By trust Employee Stock Option (right to buy) 14.69 2018-01-29 2018-01-29 4 M 0 10000 0 D 2017-01-02 2020-01-29 Common Stock 10000 26642 D Employee Stock Option (right to buy) 10.82 2018-01-29 2018-01-29 4 M 0 1000 0 D 2017-01-02 2020-01-01 Common Stock 1000 6904 I By wife Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 6/20/2016. Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person's wife on 6/17/2016. Stanley T. Crooke 2018-01-31